BECTON, DICKINSON AND COMPANY for BECTON DICKINSON AND COMPANY
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 20, 2014 | $200,000 | Replaced |
| 3rd Quarter - Amendment | Sep 21, 2015 | $100,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to safe handling of hazardous drugs Issues related to pandemic preparedness H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to device regulation
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER M LURAY | — |
| DANNY LY | — |
| ELIZABETH WOODY | — |
Medicare/Medicaid MMM
S.672, Medicare Safe Needle Disposal Coverage Act of 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH WOODY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.